List of works - Mu Moreno

A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

scientific article (publication date: August 2007)

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

scientific article published on 18 March 2013

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

scientific article published in November 2004

Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

scientific article published on 27 May 2019

Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?

scientific article published on 9 December 2013

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

scientific article

Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

scientific article published on 31 December 2019

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation

scientific article published on 01 March 2019

CYBA gene variants as biomarkers for coronary artery disease

scientific article

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

scientific article published on June 2015

Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease

scientific article published on 01 April 2019

Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

scientific article published on 01 April 2019

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

scientific article published in September 2013

Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.

scientific article published on 21 June 2004

Functional significance of single nucleotide polymorphisms within the 5′-flanking region of β2-adrenergic receptor gene

article

Gene expression profiling in whole blood of patients with coronary artery disease

scientific article

Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit

scientific article published on 01 April 2004

HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.

scientific article

Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

scientific article

Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men.

scientific article published on 20 April 2017

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

scientific article

Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.

scientific article published on September 2010

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

scientific article published on 03 February 2017

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

scientific article published on January 2016

Myocardial Remodeling in Hypertension

scientific article published on 01 September 2018

NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

scientific article published on 28 April 2005

Oxidative stress and vascular remodelling.

scientific article

Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

scientific article

Oxidative stress, endothelial dysfunction and cerebrovascular disease

scientific article published on November 2007

Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9

scientific article published on 28 December 2006

Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome

scientific article published in January 2006

Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

scientific article published in April 2017

Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients.

scientific article published on 13 September 2016

Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension

scientific article (publication date: 8 May 2003)

Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

scientific article published on 01 November 2010

Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007

scientific article

The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

scientific article published on 01 June 2011

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension

scientific article published in July 2006

The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

scientific article published on 27 October 2016

The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.

scientific article published in February 2009

The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

scientific article published on 01 March 2019

[Oxidative stress in hypertension: from the SNPs to the clinical phenotype]

scientific article published on 01 January 2004

[Superoxide anion in the physiopathology of vascular diseases]

scientific article published on 01 January 2003

List of works by Mu Moreno

A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

A synthetic peptide from transforming growth factor-β₁ type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

Association of left atrium voltage amplitude and distribution with the risk of atrial fibrillation recurrence and evolution after pulmonary vein isolation: An ultrahigh-density mapping study

Association of phagocytic NADPH oxidase activity with hypertensive heart disease: a role for cardiotrophin-1?

Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats.

Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation

CYBA gene variants as biomarkers for coronary artery disease

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease

Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis.

Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension.

Functional significance of single nucleotide polymorphisms within the 5′-flanking region of β2-adrenergic receptor gene

Gene expression profiling in whole blood of patients with coronary artery disease

Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit

HIF-1-mediated up-regulation of cardiotrophin-1 is involved in the survival response of cardiomyocytes to hypoxia.

Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men.

Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease.

Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications.

Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.

Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure

Myocardial Remodeling in Hypertension

NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

Oxidative stress and vascular remodelling.

Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

Oxidative stress, endothelial dysfunction and cerebrovascular disease

Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9

Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome

Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome

Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients.

Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension

Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension

Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007

The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension

The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes

The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.

The renal immune-inflammatory component of arterial hypertension: Emerging therapeutic strategies

[Oxidative stress in hypertension: from the SNPs to the clinical phenotype]

[Superoxide anion in the physiopathology of vascular diseases]